UK diagnostics industry calls for dialogue and delay in reimbursement reforms
This article was originally published in Clinica
Executive Summary
The UK diagnostics industry is urging the government to engage in a "genuine dialogue with chemical reagent providers and patient organisations" and delay implementing reimbursement reforms that are due to come into force on August 1.